• Homoarginine Substitution in Antimicrobial Peptides: Improving Stability Without Losing Activity

    Introduction: Antimicrobial Peptides as Next-Generation Antibiotics Antimicrobial peptides (AMPs) are gaining increasing attention as potential alternatives to traditional antibiotics. These short peptides, usually composed of 10–60 amino acids, are part of the innate immune defense systems found in many organisms. They exhibit broad-spectrum antimicrobial activity against bacteria, fungi, viruses, and parasites. Unlike conventional antibiotics that […]

  • Crossing the Blood–Brain Barrier: Can Shuttle Peptides Deliver Kv1.3 Inhibitors to the Brain?

    Abstract Peptide therapeutics are increasingly explored for the treatment of neurological disorders due to their high potency and target specificity. However, delivering peptide drugs to the brain remains a major challenge because the blood–brain barrier (BBB) restricts the entry of most large and hydrophilic molecules. One promising strategy to overcome this limitation involves the use […]

  • Amino Acid Derivatives for Peptide Synthesis

    In modern peptide labs, amino acid derivatives are the quiet workhorses that make reliable sequences possible. They improve coupling efficiency, protect sensitive functional groups, and help chemists build complex peptides with clean, reproducible outcomes. Whether you’re working on discovery projects or scaling established sequences, the quality and selection of derivatives strongly influence peptide synthesis success, […]

  • Massively Parallel Nanopore Sensing: A New Era for Peptide Profiling and Protein Identification

    Proteomics is undergoing a profound transformation. While mass spectrometry has long been the gold standard for protein analysis, researchers continue to face persistent challenges: resolving isomeric peptides, detecting subtle post-translational modifications (PTMs), distinguishing single amino acid variants (SAAVs), and validating antibody specificity with precision. As biological research increasingly demands peptide-level resolution, new technologies are emerging […]

  • From Analytical HPLC to Preparative FPLC: Optimizing Peptide Purification for Reliable Scale-Up

    Abstract Peptide purification remains one of the most critical and technically demanding steps in solid-phase peptide synthesis (SPPS). Although reversed-phase high-performance liquid chromatography (RP-HPLC) provides reliable analytical resolution of closely related impurities such as deamidation variants, isoaspartate rearrangements, and isomeric substitutions, transferring these conditions to preparative flash liquid chromatography (FPLC) often results in significant retention […]

  • Bismuth Bicycles: A Single-Atom Strategy for Next-Generation Bicyclic Peptides

    Abstract Bicyclic peptides have emerged as a powerful therapeutic modality that bridges the gap between small molecules and antibodies by combining high binding affinity with synthetic accessibility. Recent advances introduce bismuth Bicycle molecules, a novel class of constrained peptides in which three cysteine residues are coordinated to a single bismuth(III) ion, replacing conventional C3-symmetric organic […]

  • Breaking the Nuclear Barrier: How DNA–Peptide Conjugates Are Advancing Non-Viral Gene Delivery

    Abstract Non-viral gene delivery has emerged as a promising alternative to viral vectors, offering advantages in safety, scalability, and payload flexibility. Yet despite major progress in lipid nanoparticles and synthetic carriers, one fundamental biological hurdle continues to limit its effectiveness: DNA must reach the nucleus to be expressed. A recent Nature Communications study introduces a […]

  • From Thymus to Immunomodulation: Linking Physicochemical Profiles to the Biological Activity of Bovine Thymic Peptides

    Abstract Thymic peptides are recognized for their central role in immune regulation, yet many thymus-derived preparations remain insufficiently characterized despite long-standing therapeutic and nutraceutical use. This blog examines a recent comparative study evaluating two experimental bovine thymic peptide preparations alongside the clinically authorized reference Thymus Factor X® (TFX). By integrating physicochemical profiling with functional cell-based […]

  • When Binding Is Not Enough: Solving the Delivery Problem in Antisense PNA Research

    Antisense Technologies at a Crossroads: When Delivery Limits Discovery Antisense technologies have become indispensable tools in modern molecular biology and therapeutic research. Modalities such as antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and peptide nucleic acids (PNAs) allow researchers to modulate gene expression with high sequence specificity. Over the past two decades, advances in target […]

No products in the cart.